TARGET
saveGIP receptor
Glucose-dependent insulinotropic polypeptide receptor.
also known as: gipr, gip
drugs
0
catalysts
0
news
116
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Despite Zealand asset’s ‘intriguing’ weight loss, analysts underwhelmed by blood sugar numbersbiospace · 2h ago
- Significant stock movers of September: Viking soars, Longeveron slidesbiospace · 2d ago
- Kailera, Hengrui’s GLP-1/GIP candidate delivers weight, menstrual benefits to women with PMOSbiospace · 6d ago
- Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—againbiospace · 7d ago
- Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3biospace · 8d ago
- Lilly builds commercial case for GLP-1 products over Novo with indirect analysesbiospace · 8d ago
- Lilly raises diabetes weight-loss bar with amylin-Zepbound combofiercebiotech · 8d ago
- Lilly sets up next-gen obesity battle with full phase 3 retatrutide datafiercebiotech · 8d ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that